Smiths Medical has warned customers of more than 135,000 Medfusion syringe pumps about problems associated with earlier software versions. On March 5, the FDA posted an alert for 85,961 Medfusion ...

As radiopharmaceutical therapies gain momentum, new challenges are emerging in how they’re administered—especially around ...

The FDA issued three notices identifying warnings sent out by ICU Medical's Smiths Medical unit related to infusion pump ...

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

Baxter’s recall of the system involves updating instructions for use. It does not require removal from use or sale. However, ...

The mission and primary action of the collaborative is to conduct activities that improve patient safety and quality of healthcare delivery such as providing a vendor neutral database of ...

According to the agency, the effort includes more than 85,000 of the company’s Medfusion Model 3500 syringe pumps, distributed in the U.S. between 2002 and August of last year.

These programs are critical components that integrate BD’s Alaris infusion pump with hospital electronic medical record systems. Customer reports indicated delayed system responses and a backlog ...

from the department of anesthesiology and intensive care medicine at University Hospital Bonn in Germany, and colleagues wrote in the study. Automated syringe pump induction may be associated with ...